Trial intelligence / Profile preview

Chlorhexidine Gluconate for Peri-implant Mucositis

NCT02605382Phase 2Completed

Sponsor
Universidade Federal do Rio Grande do Norte
Start
Oct 2012
Primary completion
Dec 2013
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial in peri-implant mucositis comparing Chlorhexidine gluconate with Placebo (2 arms). Primary endpoint: Bleeding on probing at 6 months. Started Oct 2012; status: completed.

02

Drugs

chlorhexidine
03

Conditions

peri-implant mucositis

Beyond the preview

Go deeper on NCT02605382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02605382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call